Phibro raises fiscal 2027 sales, EBITDA guidance after record year
Phibro Animal Health reported record fiscal 2026 net sales of more than $1.5 billion and 39% growth in adjusted EBITDA, then guided fiscal 2027 sales to $1.55 billion-$1.6 billion and adjusted EBITDA to $258 million-$268 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.